Stereotactic radiotherapy (SRT) for differentiated thyroid cancer (DTC) oligometastases: an AIRO (Italian association of radiotherapy and clinical oncology) systematic review

被引：0
作者：
Valentina Lancellotta
Giuseppe Fanetti
Fabio Monari
Monica Mangoni
Renzo Mazzarotto
Luca Tagliaferri
Carlo Gobitti
Elisa Lodi Rizzini
Sara Talomo
Irene Turturici
Fabiola Paiar
Renzo Corvò
Barbara Alicja Jereczek-Fossa
Vittorio Donato
Federica Vianello
机构：
[1] Fondazione Policlinico Universitario “A. Gemelli” IRCCS,U.O.C. Radioterapia Oncologica, Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia
[2] Centro di Riferimento Oncologico di Aviano (CRO) IRCCS,Division of Radiation Oncology
[3] IRCSS Azienda Ospedaliero-Universitaria di Bologna,Division of Radiation Oncology
[4] AOUC–Careggi Hospital,Department of Radiation Oncology
[5] University Hospital Verona,Department of Radiation Oncology
[6] Istituto Oncologico Veneto – IRCCS,Radiotherapy Unit
[7] Pisa University Hospital,Radiation Oncology Unit
[8] University of Genova,Department of Radiation Oncology, IRCCS Ospedale Policlinico San Martino and Health Science Department (DISSAL)
[9] European Institute of Oncology,Division of Radiation Oncology, IEO
[10] IRCCS,Department of Oncology and Hemato
[11] University of Milan,Oncology
[12] Azienda Ospedaliera San Camillo-Forlanini,Radiation Oncology Department
来源：
La radiologia medica | 2022年 / 127卷
关键词：
Stereotactic radiotherapy; Oligometastases; Outcomes; Differentiated thyroid cancer; Toxicity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：681 / 689
页数：8
相关论文
共 468 条
  • [41] Brierley JD(2012)Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases J Neurosurg Spine 16 379-328
  • [42] Le LW(2018)Vertebral compression fracture after spine stereotactic body radiation therapy: a review of the pathophysiology and risk factors Neurosurgery 83 314-630
  • [43] Rotstein L(2012)Single-session and multisession CyberKnife radiosurgery for spine metastases-University of Pittsburgh and Georgetown University experience J Neurosurg Spine 17 11-141
  • [44] Tsang RW(2017)Quality of life in thyroid cancer patients: a literature review Clujul Med 90 147-3646
  • [45] Durante C(2013)Progress in molecular-based management of differentiated thyroid cancer Lancet 381 1058-78
  • [46] Haddy N(2014)Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial Lancet 384 319-undefined
  • [47] Baudin E(2015)Lenvatinib versus placebo in radioiodine-refractory thyroid cancer N Engl J Med 372 621-undefined
  • [48] Leboulleux S(2012)Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial J Clin Oncol 30 134-undefined
  • [49] Hartl D(2013)Cabozantinib in progressive medullary thyroid cancer J Clin Oncol 31 3639-undefined
  • [50] Travagli JP(2018)A new standardized data collection system for interdisciplinary thyroid cancer management: thyroid COBRA Eur J Intern Med 53 73-undefined
12345678910